KNTE
Kinnate Biopharma Inc.
Director and 10% owner Carl L Gordon bought $4.1M of Kinnate Biopharma Inc.
Bought$4,086,235
$2.80Price
1,460,932Shares
+331%Stake
What KNTE did for a copier
- $1,000 copied at Mon, May 8 close, $3.10
- $1,013
- S&P 500, same days
- +5.8%
Measured over 30 trading days, to the Jun 21 close.
Carl L Gordon's record
14 other buys with 3 months of prices since 2016: on average −5.2% against the S&P 500, and 7 of 14 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 4. Filed Mon, May 8, 1:11 PM ET, during the session. Returns use the May 8 close and the Jun 21 close. Not investment advice.